Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
26,555,317
-
Share change
-
+26,555,317
-
Total reported value
-
$1,118,824,007
-
Price per share
-
$42.16
-
Number of holders
-
58
-
Value change
-
+$1,118,824,003
-
Number of buys
-
58
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q3 2015
As of 30 Sep 2015,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,555,317 shares.
The largest 10 holders included
Third Rock Ventures, LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT CO, Partner Fund Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, RA CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, SABBY MANAGEMENT, LLC, and RS INVESTMENT MANAGEMENT CO LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.